Industry
Featured experience
Novo Nordisk acquisition of certain Catalent sites from Novo Holdings
We are advising Novo Nordisk on the acquisition
AbbVie $15 billion senior notes offering
The investment-grade offering comprised seven tranches
Auna $360 million U.S. IPO
We advised Auna on its U.S. IPO and NYSE listing
Trial victory in patent infringement case for Magnolia Medical Technologies
We served as lead trial counsel for Magnolia Medical in an action against its sole competitor
NGM Biopharmaceuticals, Inc. Initial Public Offering
Davis Polk advised the underwriters in connection with an initial public offering of 7,521,394 shares of common stock of NGM…
Zai Lab Limited $230 Million Follow-On Offering of American Depositary Shares
Davis Polk advised Zai Lab Limited in connection with its follow-on offering of $230 million of American Depositary Shares…
Magenta Therapeutics, Inc. $64.8 Million Follow-On Offering of Common Stock
Davis Polk advised the joint book-running managers and representatives of the underwriters in connection with the $64.8…
TransMedics Group, Inc. Initial Public Offering
Davis Polk advised the representatives of the underwriters in connection with the $104.7 million initial public offering of…
Davis Polk Advises Pernix on Completing Sale of Substantially All of Its Assets to Currax Holdings LLC
Davis Polk advised Pernix Therapeutics Holdings, Inc. in connection with the sale of substantially all of its assets to…
Natera, Inc. $100 Million Follow-On Public Offering
Davis Polk advised the several underwriters in connection with the follow-on offering of 5,263,158 shares of common stock of…
Turning Point Therapeutics, Inc. Initial Public Offering
Davis Polk advised the representatives of the several underwriters in connection with a $191.5 million initial public…
Millendo Therapeutics, Inc. SEC-Registered At-The-Market Offering Program
Davis Polk advised a sales agent in connection with the establishments of an SEC-registered at-the-market offering program…
NanoString Technologies, Inc. Follow-on Offering
Davis Polk advised the joint book-running managers and the lead manager in connection with a $119 million public…
Davis Polk Advises ShockWave Medical, Inc. on Its $111.4 Million Initial Public Offering
Davis Polk advised ShockWave Medical, Inc. on its SEC-registered initial public offering of 6,555,000 shares of common stock…